Showing results (661-670 of 3,353) with videos related to

Sort By:
Pageof 336
Gynecologic Oncology|February 6, 2007
Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trialsBradley J Monk, Chunqiao Tian, Peter G Rose, et al.
Archives of Orthopaedic and Trauma Surgery|November 29, 2019
The use of accelerometer-based navigation for coronal TKA alignment: a prospective, single surgeon comparative studyMark Zhu, Elizabeth Lindsay, Andre Keenan, et al.
Midwifery|February 12, 2013
Evaluating midwifery units (EMU): lessons from the pilot studyAmy R Monk, Sally K Tracy, Maralyn Foureur, et al.
Pharmacological Reviews|February 7, 2013
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXVII. Complement peptide C5a, C4a, and C3a receptorsAndreas Klos, Elisabeth Wende, Kathryn J Wareham, et al.
Clinical Epigenetics|February 5, 2020
Comprehensive analysis of PM20D1 QTL in Alzheimer's diseaseJose Vicente Sanchez-Mut, Liliane Glauser, David Monk, et al.
Clinical Advances in Hematology & Oncology : H&O|November 17, 2020
PARP inhibition in recurrent ovarian cancerKathleen N Moore, Bhavana Pothuri, Bradley Monk, et al.
Plos One|January 28, 2014
Docosahexaenoic acid decreases pro-inflammatory mediators in an in vitro murine adipocyte macrophage co-culture modelAnna A De Boer, Jennifer M Monk, Lindsay E Robinson
The Journal of Endocrinology|November 21, 2008
Complement C5a receptors in the pituitary gland: expression and functionKaren Francis, B Mary Lewis, Peter N Monk, et al.
Glia|April 18, 2009
Astrocyte function and role in motor neuron disease: a future therapeutic target?Daniel Blackburn, Siranush Sargsyan, Peter N Monk, et al.
Applied Optics|April 1, 2020
Efficiency enhancement of ultrathin CIGS solar cells by optimal bandgap grading: erratumFaiz Ahmad, Tom H Anderson, Peter B Monk, et al.
Pageof 336